Sorafenib inhibitor is a kinase inhibitor drug approved for the treatment of primary kidney cancer.
Domain | sorafenibinhibitor.com |
---|---|
Homepage URL | https://sorafenibinhibitor.com/evaluations-regarding-individual-and-area-level-socioeconomic-reputation-because-proxy-servers/ |
Keywords | sorafenib inhibitor trk receptor agonist genetic gain |
Sprache | englisch |